Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Biothera Appoints CEO

This article was originally published in Scrip

Executive Summary

Biothera Pharmaceutical Inc. has appointed Barry Labinger CEO – effective Dec. 14, 2015. With nearly 30 years' experience, Labinger joins the company having most recently served as executive vice president (VP) and president, biosciences division at Emergent BioSolutions, Inc. Previously he was executive VP and chief commercial officer of Human Genome Sciences, Inc. and prior to this he was division VP of 3M Pharmaceuticals. Prior to 3M, he was senior VP and general manager of commercial operations for Immunex Corporation.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst